Myasthenia gravis patient registry in China
Part of Brain & nervous system, Cancer, Immune system & allergy clinical trials.
This study creates a registry to collect information about people with myasthenia gravis in China. By joining, you help researchers learn more about the condition and how it affects different people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have muscle weakness that comes and goes, and gets worse with activity but improves with rest.
- You or your guardian can understand and sign a consent form.
- You have had a positive Tensilon test, OR nerve stimulation tests show a certain pattern, OR you tested positive for specific antibodies (AChR, MuSK, or LRP4).
- You do not have a mental illness that would make it hard to cooperate.
- You are not in extremely critical condition or have multiple organ failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with myasthenia gravis who are patients at Peking Union Medical College Hospital to learn more about the disease and how it affects patients over time.
This study follows people with suspected or confirmed myasthenia gravis (a condition that causes muscle weakness that gets worse with use). It uses several specialized nerve and antibody tests to make a more precise diagnosis and tracks you over time to see how well these methods work.
This study is a patient registry that tracks the experiences of people with myasthenia gravis over time. It aims to better understand the condition and improve care, using a smartphone, tablet, or computer to share information.
This trial is a global registry for people with myasthenia gravis (MG). It collects information to help researchers better understand MG and improve care.
This trial is a registry that collects your clinical information and biological samples to help researchers better understand myasthenia gravis. You may benefit indirectly by helping studies that could improve future care for people with this condition.
This study tracks the safety and effectiveness of newer drugs for myasthenia gravis. If you have started or are about to start a new medication for MG, this registry can help doctors learn more about how well these treatments work in real life.
Hear when a new Myasthenia Gravis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.